Table 1.
Studya | n | Outcome (persistence) | AT-II blockers | ACE-inhibitors | Calcium antagonists | Beta-blockers | Diuretics |
---|---|---|---|---|---|---|---|
Blooms 1998 | 21,723 | 1-year persistence | 64% | 58% | 50% | 43% | 38% |
Caro 1999 | 22,918 | 4.5-year persistence | neb | 53% | 47% | 49% | 40% |
Morgan 2004 | 82,824 | 1-year persistence | 56% | 56% | 52% | 54% | 49% |
Polluzzi 2005 | 6,043 | 3-year persistence* | 52% | 43% | 39% | 47% | 23% |
Simons 2008 | 48,690 | 33-month persistence | 84% | 84% | 72% | ne | ne |
All theses studies are retrospective.
not evaluated.